Vitamin K2 Market

Vitamin K2 Market by Product Type (MK-4, MK-7), Source (Natural, Synthetic), Form (Capsules & Tablets, Powder & Crystalline, Oils & Liquid), Application (Pharmaceutical, Functional Food & Beverages, Health Supplements), Function - Global Forecast to 2029

Report Code: FB 9049 Jun, 2024, by marketsandmarkets.com

The global vitamin K2 market is on a trajectory of significant expansion, with an estimated value projected to reach USD 265 million by 2029 from the 2024 valuation of USD 140 million, displaying a promising Compound Annual Growth Rate (CAGR) of 13.7%. As scientific research continues to highlight the benefits of Vitamin K2, particularly in calcium metabolism and the prevention of arterial calcification, more individuals are incorporating this nutrient into their diets. This heightened awareness is especially prevalent among aging populations, who are at greater risk for osteoporosis and cardiovascular diseases, thereby fueling demand for Vitamin K2 supplements.

Another significant contributor to market expansion is the rise of the health and wellness trend. Consumers worldwide are becoming more proactive about their health, seeking preventive measures to avoid chronic diseases. This shift is evident in the growing popularity of dietary supplements and functional foods fortified with essential nutrients like Vitamin K2. Moreover, advancements in the production and formulation of Vitamin K2 supplements are also playing a crucial role in the market’s upward trajectory. Innovations such as microencapsulation and improved delivery systems have enhanced the bioavailability and efficacy of Vitamin K2, making supplements more effective and appealing to consumers. These advancements not only improve the absorption of Vitamin K2 in the body but also extend the shelf life of products, ensuring that consumers receive the maximum benefits from their supplements.

Vitamin K2 Market

To know about the assumptions considered for the study, Request for Free Sample Report

Vitamin K2 Market Opportunities

To know about the assumptions considered for the study, download the pdf brochure

Market Dynamics

Drivers: Growth in health consciousness among consumers and increasing health expenditure

The Vitamin K2 market is experiencing robust growth, primarily driven by the increasing health consciousness among consumers and the rise in health expenditure globally. As more individuals become aware of the importance of preventive healthcare, they are seeking out dietary supplements that can support their long-term well-being. This trend is evident across various demographics, from young adults focused on maintaining their health to older populations looking to manage age-related health issues. The growing emphasis on holistic health and wellness is leading consumers to invest in products that offer specific health benefits, such as improved bone density and cardiovascular health, which are directly linked to Vitamin K2. Additionally, higher disposable incomes and greater health expenditure are enabling consumers to spend more on premium health products, further boosting the demand for Vitamin K2 supplements.

Restraints: Inconsistency in regulatory norms governing vitamin K2

Despite the promising growth prospects, the Vitamin K2 market faces significant challenges due to the inconsistency in regulatory norms across different regions. These regulatory disparities can create barriers for manufacturers and marketers, complicating the process of bringing new Vitamin K2 products to market. Different countries have varying guidelines and standards for the production, labeling, and marketing of dietary supplements, including Vitamin K2. This lack of uniformity can lead to increased costs for compliance and potential delays in product launches. Moreover, stringent regulations in certain regions can limit market entry for new players, hindering the overall growth of the Vitamin K2 market. Navigating these regulatory complexities requires substantial investment in legal and regulatory expertise, which can be a restraint for smaller companies.

Opportunities: Growing demand for natural and functional foods

The growing demand for natural and functional foods presents a significant opportunity for the Vitamin K2 market. Consumers are increasingly seeking out food products that not only provide essential nutrients but also offer additional health benefits. This trend towards functional foods is driven by a desire for more natural and holistic approaches to health and nutrition. Vitamin K2, known for its role in supporting bone and cardiovascular health, is a valuable ingredient in this market. Manufacturers are capitalizing on this opportunity by incorporating Vitamin K2 into a variety of food products, including dairy products, fermented foods, and nutritional bars. The preference for natural ingredients further enhances the appeal of Vitamin K2, as it can be sourced from natural origins such as fermented soybeans (natto) and certain cheeses. This growing demand for functional and natural foods is set to drive the expansion of the Vitamin K2 market.

Challenges: Lack of consumer awareness regarding benefits specific to vitamin K2

One of the key challenges facing the Vitamin K2 market is the lack of consumer awareness regarding its specific benefits. While there is a general understanding of the importance of vitamins for health, the unique benefits of Vitamin K2, such as its role in calcium metabolism and preventing arterial calcification, are not widely known. This lack of awareness can limit consumer demand and slow market growth. Many consumers may not differentiate between Vitamin K1 and Vitamin K2, leading to confusion and underutilization of Vitamin K2 supplements. Addressing this challenge requires concerted efforts in education and marketing to inform consumers about the specific advantages of Vitamin K2. Effective communication strategies, including clear labeling, informative campaigns, and endorsements by health professionals, are essential to bridge this knowledge gap and drive greater adoption of Vitamin K2 products.

Market Ecosystem

Top Companies in Vitamin K2 Market

Mk-7 Product Type is Witnessing Higher Growth During the Forecast Period. 

Menaquinone-7 or MK-7 is the most studied menaquinone due to its high bioavailability, longer half-life, and more than three decades of clinical research. Furthermore,  Vitamin K2 MK-7, specifically MenaQ7 and vitaMK7, represents a pivotal advancement in nutritional science, renowned for its dual benefits in bone and cardiovascular health. Distinct from its K1 counterpart, K2 MK-7's superior bioavailability and extended half-life in the body make it optimal for promoting calcium utilization towards bone strength while preventing arterial calcification.

As consumer awareness grows and dietary deficiencies persist, the market potential for K2 MK-7 continues to expand, driven by increasing demand for scientifically validated supplements that address fundamental health challenges across diverse demographic segments.

Pharmaceuticals Emerge As the Second Dominant Application Segment in the Vitamin K2 Market.

The pharmaceutical sector is driven by its extensive therapeutic benefits and increasing incorporation into medical treatments. Vitamin K2’s importance in the pharmaceutical sector is underscored by its application in the prevention and treatment of osteoporosis, cardiovascular diseases, and certain types of cancer. As research continues to unveil the extensive health benefits of vitamin K2, its integration into pharmaceutical products is becoming increasingly prevalent.

Moreover, the potential anticancer properties of vitamin K2 are garnering attention within the pharmaceutical industry. Studies have suggested that vitamin K2 can induce apoptosis in cancer cells and inhibit their proliferation. According to an NCBI study, vitamin K2 induces differentiation and apoptosis in a wide array of human cancer cell lines. However, it is noteworthy that vitamin K2-mediated apoptosis proceeds much more slowly than the apoptosis induced by conventional anticancer agents. The inclusion of vitamin K2 in pharmaceutical products could, therefore, open new avenues for therapeutic interventions, providing patients with innovative treatment options.

Asia Pacific Is The Fastest-Growing Market For Vitamin K2 Among The Regions.

The Asia Pacific region is emerging as the fastest-growing market for Vitamin K2, driven by a combination of demographic, economic, and lifestyle factors. One of the primary drivers of this growth is the region’s rapidly aging population. Countries such as Japan, China, and South Korea are experiencing significant increases in their elderly populations, who are more prone to bone-related ailments like osteoporosis and cardiovascular issues. This demographic shift is creating a substantial demand for nutritional supplements that support bone health and prevent arterial calcification, making Vitamin K2 a sought-after nutrient.

Additionally, The robust growth of the e-commerce sector in the Asia Pacific (APAC) region has significantly facilitated easy access to a wide range of Vitamin K2 products, contributing to the market's expansion. One of the main advantages is the proliferation of online retail platforms, such as Amazon, Alibaba, and other regional e-commerce giants. These platforms have not only increased the visibility of Vitamin K2 supplements but have also allowed for a broader distribution network, reaching consumers in even the most remote areas.

Consumers now have the convenience of shopping from their homes or workplaces, offering a seamless purchasing experience. This accessibility has become even more appealing due to the variety of choices and competitive pricing available on e-commerce platforms. Additionally, online platforms often provide comprehensive product information, customer reviews, and expert advice, empowering consumers to make informed decisions about their health and wellness purchases.

Asia Pacific Vitamin K2 Market Size, and Share

Key Market Players

The key players in this market include Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-OIL MILLS INC. (Japan), Novozymes A/S (Denmark), BASF SE (Germany), Sungen Bioscience Co.,Ltd. (China), Vesta Nutra (US), Richen Nutritional Technology Co., Ltd. (China), Menadiona (Spain), and GENOFOCUS (Korea)

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

:

Report Metric

Details

Market size estimation

2024–2029

Base year considered

2023

Forecast period considered

2024–2029

Units considered

Value (USD Million), Volume (Tons)

Segments Covered

By Product Type, Form, Source, Application, Function, and Region

Regions covered

North America, Europe, Asia Pacific, and RoW

Companies studied

  • Gnosis By Lesaffre (Nattopharma) (Norway)
  • Kappa Bioscience As (Balchem Corp.) (US)
  • J-OIL MILLS, INC. (Japan)
  • Novozymes A/S (Denmark)
  • BASF SE (Germany)
  • Sungen Bioscience Co.,Ltd (China)
  • Vesta Nutra (US)
  • Richen (China)
  • Menadiona (Spain)
  • Genofocus (South Korea)
  • Angelyeast Co., Ltd. (China)
  • Geneferm Biotechnology Co., Ltd. (Taiwan)
  • Nakoda Chemical Ltd. (India)
  • Haihang Industry (China)
  • Chemicea Limited (India)
  • Kyowa Hakko U.S.A., Inc. (US)

This research report categorizes the vitamin k2 market, based on product type, form, source, application, function, and region.

Target Audience

  • Vitamin k2 Manufacturers
  • Food & Beverage Producers
  • Pharmaceutical companies
  • Food Processing Manufacturers
  • Government Agencies (related to food safety and regulations such as FDA, EFSA, and FSSAI)

Vitamin K2 Market:

By Product type
  • MK-4
  • MK-7
By Form
  • Capsules & Tablets
  • Powder & Crystalline
  • Oils & Liquid   
By Source
  • Natural
  • Synthetic
By Application
  • Pharmaceuticals
  • Functional Food & Beverages
  • Health Supplements
By Function (Qualitative)
  • Bone & Cardiovascular Health
  • Blood Health & Clotting
  • Anti-inflammatory & Immune Support
  • Other Functions
By Region
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

Recent Developments

  • In April 2022, GF Fermentech, a subsidiary of Genofocus, introduced a higher-purity variant of its MediQ7 range of vitamin K2 ingredients, named MediQ7 Pure. Derived from Bacillus subtilis natto sourced from traditional Korean fermented food Cheonggukjang, this product boasts over 96% concentration and 99.9% trans-type Menaquinone 7, aligning with USP standards. The ingredients are vegan, kosher, halal, GMP, ISO 9001, and ISO 22000 certified.
  • In January 2021, Menadiona launched its Vitamin K2 MK-7 grade. Menadiona has been a consistent supplier of Vitamin K2 MK-4 (Menatetrenone) for the medical treatment of osteoporosis. With the COVID-19 pandemic highlighting a potential link between Vitamin K2 deficiency and the risk of developing the disease, MENADIONA has expanded its product line to include the new MK-7 grade, suitable for nutraceutical formulations in various forms, such as gel, oil, or capsules.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 31)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
                    TABLE 1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE 
           1.3.1 MARKET SEGMENTATION
           1.3.2 REGIONS COVERED
           1.3.3 YEARS CONSIDERED
    1.4 UNIT CONSIDERED 
           1.4.1 CURRENCY UNIT
                    TABLE 2 USD EXCHANGE RATES, 2020–2023
           1.4.2 VOLUME UNIT
    1.5 STAKEHOLDERS 
    1.6 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 36)
    2.1 RESEARCH DATA 
           FIGURE 1 VITAMIN K2 MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key insights from industry experts
                    2.1.2.3 Breakdown of primaries
    2.2 MARKET SIZE ESTIMATION 
           2.2.1 TOP-DOWN APPROACH
                    FIGURE 2 VITAMIN K2 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
           2.2.2 SUPPLY-SIDE ANALYSIS
                    FIGURE 3 VITAMIN K2 MARKET SIZE CALCULATION: SUPPLY-SIDE ANALYSIS
           2.2.3 BOTTOM-UP APPROACH
                    FIGURE 4 VITAMIN K2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    2.3 DATA TRIANGULATION 
           FIGURE 5 DATA TRIANGULATION
    2.4 RESEARCH ASSUMPTIONS 
    2.5 LIMITATIONS AND RISK ASSESSMENT 
    2.6 RECESSION IMPACT ANALYSIS 
           2.6.1 RECESSION MACROINDICATORS
                    FIGURE 6 INDICATORS OF RECESSION
                    FIGURE 7 GLOBAL INFLATION RATE, 2012–2022
                    FIGURE 8 GLOBAL GROSS DOMESTIC PRODUCT, 2012–2022 (USD TRILLION)
                    FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON VITAMIN K2 MARKET
                    FIGURE 10 GLOBAL VITAMIN K2 MARKET: CURRENT FORECAST VS. RECESSION FORECAST
 
3 EXECUTIVE SUMMARY (Page No. - 50)
    TABLE 3 VITAMIN K2 MARKET SNAPSHOT, 2024 VS. 2029 
    FIGURE 11 MK-7 SEGMENT TO HOLD LARGER MARKET SIZE IN 2024 
    FIGURE 12 POWDER AND CRYSTALLINE TO BE LARGEST APPLICATION FORM SEGMENT IN 2024 
    FIGURE 13 NATURAL SOURCE SEGMENT TO DOMINATE MARKET IN 2024 
    FIGURE 14 PHARMACEUTICALS APPLICATION SEGMENT TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD 
    FIGURE 15 ASIA PACIFIC HELD LARGEST MARKET SHARE IN 2023 
 
4 PREMIUM INSIGHTS (Page No. - 55)
    4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN VITAMIN K2 MARKET 
           FIGURE 16 GROWING CONSUMER PREFERENCES FOR NATURAL AND ORGANIC PRODUCTS TO DRIVE DEMAND FOR VITAMIN K2
    4.2 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE AND KEY COUNTRY 
           FIGURE 17 MK-7 SEGMENT AND CHINA TO ACCOUNT FOR SIGNIFICANT MARKET SHARES IN 2024
    4.3 VITAMIN K2 MARKET: SHARE OF MAJOR REGIONAL SUBMARKETS 
           FIGURE 18 US ACCOUNTED FOR LARGEST SHARE IN 2023
    4.4 VITAMIN K2 MARKET, BY PRODUCT TYPE AND REGION 
           FIGURE 19 MK-7 SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.5 VITAMIN K2 MARKET, BY APPLICATION FORM 
           FIGURE 20 POWDER AND CRYSTALLINE SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
    4.6 VITAMIN K2 MARKET, BY SOURCE 
           FIGURE 21 NATURAL SEGMENT TO ACCOUNT FOR LARGER MARKET SIZE DURING FORECAST PERIOD
    4.7 VITAMIN K2 MARKET, BY APPLICATION 
           FIGURE 22 HEALTH SUPPLEMENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 59)
    5.1 INTRODUCTION 
    5.2 MACROECONOMIC INDICATORS 
           5.2.1 RISING GDP AND POPULATION
                    FIGURE 23 GLOBAL POPULATION GROWTH, 1950–2050 (BILLION)
                    FIGURE 24 GDP GROWTH, 2016–2023 (USD TRILLION)
           5.2.2 RISE IN HEALTH CONCERNS AND DISEASE INCIDENCES
                    FIGURE 25 GLOBAL TRENDS IN DEATHS DUE TO CVD, 1990-2030
           5.2.3 INCREASE IN CONSUMPTION OF DIETARY FIBERS
    5.3 MARKET DYNAMICS 
           FIGURE 26 VITAMIN K2 MARKET: MARKET DYNAMICS
           5.3.1 DRIVERS
                    5.3.1.1 Rising health consciousness among consumers
                               FIGURE 27 OECD HEALTH SPENDING AS SHARE OF GDP, 2017–2021
                    5.3.1.2 Growing research and development activities
                               FIGURE 28 GLOBAL EXPANSION OF VITAMIN K2 RESEARCH OVER THREE DECADES  (1990-2020)
           5.3.2 RESTRAINTS
                    5.3.2.1 Inconsistency in regulatory norms
                    5.3.2.2 Price volatility of raw materials
           5.3.3 OPPORTUNITIES
                    5.3.3.1 Growing demand for natural and plant-based ingredients
                    5.3.3.2 Rising need for personalized nutrition and customized products
                    5.3.3.3 Untapped applications
           5.3.4 CHALLENGES
                    5.3.4.1 Lack of consumer awareness regarding specific health benefits
                    5.3.4.2 High research and development costs
 
6 INDUSTRY TRENDS (Page No. - 69)
    6.1 INTRODUCTION 
    6.2 SUPPLY CHAIN ANALYSIS 
           FIGURE 29 VITAMIN K2 MARKET: SUPPLY CHAIN ANALYSIS
    6.3 VALUE CHAIN ANALYSIS 
           FIGURE 30 VALUE CHAIN ANALYSIS: VITAMIN K2 MARKET
           6.3.1 RAW MATERIAL SOURCING
           6.3.2 MANUFACTURING AND PROCESSING
                    6.3.2.1 Product formulation and development
           6.3.3 QUALITY ASSURANCE AND CERTIFICATION
           6.3.4 MARKETING AND DISTRIBUTION
    6.4 TRADE ANALYSIS 
           6.4.1 EXPORT SCENARIO
                    FIGURE 31 EXPORT VALUE OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629) FOR KEY COUNTRIES, 2019–2023 (USD THOUSAND)
           6.4.2 IMPORT SCENARIO
                    FIGURE 32 IMPORT VALUE OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629) FOR KEY COUNTRIES, 2019–2023 (USD THOUSAND)
                    TABLE 4 TOP 10 EXPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629),  2019–2023 (USD THOUSAND)
                    TABLE 5 TOP 10 EXPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629),  2019–2023 (TON)
                    TABLE 6 TOP 10 IMPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629),  2019–2023 (USD THOUSAND)
                    TABLE 7 TOP 10 IMPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629),  2019–2023 (TON)
    6.5 TECHNOLOGY ANALYSIS 
           6.5.1 KEY TECHNOLOGY
                    6.5.1.1 Fermentation technology
           6.5.2 COMPLEMENTARY TECHNOLOGY
                    6.5.2.1 Encapsulation technology
           6.5.3 ADJACENT TECHNOLOGY
                    6.5.3.1 Biotechnology
    6.6 PRICING ANALYSIS 
           6.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT TYPE
                    TABLE 8 AVERAGE SELLING PRICE (ASP), BY PRODUCT TYPE, 2020–2023 (USD/TON)
                    FIGURE 33 AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE, 2020–2023 (USD/TON)
           6.6.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
                    TABLE 9 AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2023 (USD/TON)
    6.7 ECOSYSTEM ANALYSIS 
           6.7.1 DEMAND SIDE
           6.7.2 SUPPLY SIDE
                    FIGURE 34 KEY PLAYERS IN VITAMIN K2 ECOSYSTEM
                    TABLE 10 VITAMIN K2 MARKET ECOSYSTEM
    6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
           FIGURE 35 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
    6.9 PATENT ANALYSIS 
           FIGURE 36 NUMBER OF PATENTS GRANTED FOR VITAMIN K2 MARKET, 2013–2023
           FIGURE 37 REGIONAL ANALYSIS OF PATENTS GRANTED FOR VITAMIN K2 MARKET,  2013–2023
           6.9.1 LIST OF MAJOR PATENTS
                    TABLE 11 LIST OF MAJOR PATENTS PERTAINING TO VITAMIN K2, 2020–2023
    6.10 KEY CONFERENCES AND EVENTS, 2024–2025 
           TABLE 12 VITAMIN K2 MARKET: KEY DETAILED LIST OF CONFERENCES AND EVENTS, 2024–2025
    6.11 REGULATORY LANDSCAPE 
           6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 13 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 14 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS
                    TABLE 15 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS
                    6.11.1.1 Regulations in North America
                               6.11.1.1.1 US
                               6.11.1.1.2 Canada
                    6.11.1.2 Regulations in Europe
                    6.11.1.3 Regulations in Asia Pacific
                               6.11.1.3.1 China
                               6.11.1.3.2 India
    6.12 PORTER’S FIVE FORCES ANALYSIS 
                    TABLE 16 IMPACT OF PORTER’S FIVE FORCES ON VITAMIN K2 MARKET
                    FIGURE 38 PORTER’S FIVE FORCES ANALYSIS: VITAMIN K2 MARKET
           6.12.1 INTENSITY OF COMPETITIVE RIVALRY
           6.12.2 BARGAINING POWER OF SUPPLIERS
           6.12.3 BARGAINING POWER OF BUYERS
           6.12.4 THREAT OF NEW ENTRANTS
           6.12.5 THREAT OF SUBSTITUTES
    6.13 KEY STAKEHOLDERS AND BUYING CRITERIA 
           6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
                    FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES
                    TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES
           6.13.2 BUYING CRITERIA
                    FIGURE 40 KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES
                    TABLE 18 KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES
    6.14 CASE STUDY ANALYSIS 
           6.14.1 ESTABLISHING DISTINCT RECOMMENDED DIETARY INTAKE TO PROMOTE HEALTHIER DIETARY CHOICES
           6.14.2 ENHANCING ABILITY IN NUTRACEUTICAL FORMULATIONS FOR IMPROVED QUALITY AND EFFICACY
    6.15 INVESTMENT AND FUNDING SCENARIO 
                    FIGURE 41 INVESTMENT AND FUNDING SCENARIO, 2019–2024 (USD MILLION)
 
7 VITAMIN K2 MARKET, BY FUNCTION (Page No. - 96)
    7.1 INTRODUCTION 
    7.2 BONE AND CARDIOVASCULAR HEALTH 
           7.2.1 COMPREHENSIVE HEALTH BENEFITS TO DRIVE MARKET
    7.3 BLOOD HEALTH AND CLOTTING 
           7.3.1 EFFICACY IN MANAGING CLOTTING DISORDERS TO BOOST MARKET GROWTH
    7.4 ANTI-INFLAMMATORY AND IMMUNITY 
           7.4.1 THERAPEUTIC POTENTIAL AND IMMUNITY-SUPPORTING PROPERTIES TO SUPPORT MARKET GROWTH
    7.5 OTHER FUNCTIONS 
 
8 VITAMIN K2 MARKET, BY PRODUCT TYPE (Page No. - 100)
    8.1 INTRODUCTION 
           TABLE 19 PRODUCT TYPE: OVERVIEW
           FIGURE 42 MK-7 SEGMENT TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD
           TABLE 20 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
           TABLE 21 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
           TABLE 22 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (TON)
           TABLE 23 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (TON)
    8.2 MK-4 
           8.2.1 POTENTIAL BENEFITS IN BONE AND CARDIOVASCULAR HEALTH TO DRIVE MARKET GROWTH
                    TABLE 24 MK-4: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
                    TABLE 25 MK-4: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
                    TABLE 26 MK-4: VITAMIN K2 MARKET, BY REGION, 2020–2023 (TON)
                    TABLE 27 MK-4: VITAMIN K2 MARKET, BY REGION, 2024–2029 (TON)
    8.3 MK-7 
           8.3.1 HIGH BIOAVAILABILITY TO PROPEL MARKET GROWTH
                    TABLE 28 MK-7: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
                    TABLE 29 MK-7: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
                    TABLE 30 MK-7: VITAMIN K2 MARKET, BY REGION, 2020–2023 (TON)
                    TABLE 31 MK-7: VITAMIN K2 MARKET, BY REGION, 2024–2029 (TON)
 
9 VITAMIN K2 MARKET, BY APPLICATION FORM (Page No. - 107)
    9.1 INTRODUCTION 
           FIGURE 43 POWDER AND CRYSTALLINE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
           TABLE 32 VITAMIN K2 MARKET, BY APPLICATION FORM, 2020–2023 (USD MILLION)
           TABLE 33 VITAMIN K2 MARKET, BY APPLICATION FORM, 2024–2029 (USD MILLION)
    9.2 CAPSULES AND TABLETS 
           9.2.1 ABILITY TO CATER TO DIVERSE CONSUMER NEEDS AND PREFERENCES TO DRIVE MARKET
                    TABLE 34 CAPSULES AND TABLETS: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
                    TABLE 35 CAPSULES AND TABLETS: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
    9.3 POWDER AND CRYSTALLINE 
           9.3.1 SURGING DEMAND FOR CUSTOMIZABLE DOSAGES AND HIGH PURITY TO PROPEL MARKET GROWTH
                    TABLE 36 POWDER AND CRYSTALLINE: VITAMIN K2 MARKET, BY REGION,  2020–2023 (USD MILLION)
                    TABLE 37 POWDER AND CRYSTALLINE: VITAMIN K2 MARKET, BY REGION,  2024–2029 (USD MILLION)
    9.4 LIQUIDS 
           9.4.1 GROWING NEED FOR SUPPLEMENTS WITH ENHANCED BIOAVAILABILITY TO BOOST SEGMENT GROWTH
                    TABLE 38 LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
                    TABLE 39 LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
 
10 VITAMIN K2 MARKET, BY SOURCE (Page No. - 112)
     10.1 INTRODUCTION 
               FIGURE 44 NATURAL SEGMENT TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD
               TABLE 40 VITAMIN K2 MARKET: BY SOURCE, 2020–2023 (USD MILLION)
               TABLE 41 VITAMIN K2 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
     10.2 NATURAL 
             10.2.1 INCREASING CONSUMER PREFERENCE FOR NON-GMO SUPPLEMENTS TO BOOST MARKET GROWTH
                       TABLE 42 NATURAL: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
                       TABLE 43 NATURAL: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
     10.3 SYNTHETIC 
             10.3.1 LOW PRODUCTION COST TO DRIVE MARKET
                       TABLE 44 SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
                       TABLE 45 SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
 
11 VITAMIN K2 MARKET, BY APPLICATION (Page No. - 116)
     11.1 INTRODUCTION 
               TABLE 46 APPLICATION: OVERVIEW
               FIGURE 45 HEALTH SUPPLEMENTS SEGMENT TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD
               TABLE 47 VITAMIN K2 MARKET: BY APPLICATION, 2020–2023 (USD MILLION)
               TABLE 48 VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
     11.2 PHARMACEUTICALS 
             11.2.1 RISING GOVERNMENT INVESTMENTS IN DEVELOPMENT OF NEW FORMULATIONS TO DRIVE MARKET
                       TABLE 49 PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
                       TABLE 50 PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
     11.3 FUNCTIONAL FOODS AND BEVERAGES 
             11.3.1 GROWING DEMAND FOR FORTIFIED FUNCTIONAL FOODS TO PROPEL MARKET GROWTH
                       TABLE 51 FUNCTIONAL FOODS AND BEVERAGES: VITAMIN K2 MARKET, BY REGION,  2020–2023 (USD MILLION)
                       TABLE 52 FUNCTIONAL FOODS AND BEVERAGES: VITAMIN K2 MARKET, BY REGION,  2024–2029 (USD MILLION)
     11.4 HEALTH SUPPLEMENTS 
             11.4.1 INCREASED AWARENESS REGARDING ASSOCIATED HEALTH BENEFITS TO DRIVE MARKET
                       TABLE 53 HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
                       TABLE 54 HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
 
12 VITAMIN K2 MARKET, BY REGION (Page No. - 123)
     12.1 INTRODUCTION 
               FIGURE 46 ITALY TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
               TABLE 55 VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
               TABLE 56 VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
               TABLE 57 VITAMIN K2 MARKET, BY REGION, 2020–2023 (TON)
               TABLE 58 VITAMIN K2 MARKET, BY REGION, 2024–2029 (TON)
     12.2 NORTH AMERICA 
               TABLE 59 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
               TABLE 60 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
               TABLE 61 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (TON)
               TABLE 62 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (TON)
               TABLE 63 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE,  2020–2023 (USD MILLION)
               TABLE 64 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE,  2024–2029 (USD MILLION)
               TABLE 65 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (TON)
               TABLE 66 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (TON)
               TABLE 67 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM,  2020–2023 (USD MILLION)
               TABLE 68 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM,  2024–2029 (USD MILLION)
               TABLE 69 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2020–2023 (USD MILLION)
               TABLE 70 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
               TABLE 71 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION,  2020–2023 (USD MILLION)
               TABLE 72 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION,  2024–2029 (USD MILLION)
             12.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
                       FIGURE 47 INFLATION IN NORTH AMERICA: COUNTRY-LEVEL DATA, 2017–2022
                       FIGURE 48 NORTH AMERICA: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
             12.2.2 US
                       12.2.2.1 Growing awareness regarding importance of preventive health measures to drive market
                                   TABLE 73 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
                                   TABLE 74 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
             12.2.3 CANADA
                       12.2.3.1 Increasing focus on preventive healthcare and natural products to propel market
                                   TABLE 75 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
                                   TABLE 76 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
             12.2.4 MEXICO
                       12.2.4.1 High prevalence of chronic lifestyle diseases to drive market
                                   TABLE 77 MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
                                   TABLE 78 MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
     12.3 EUROPE 
               FIGURE 49 EUROPE: VITAMIN K2 MARKET SNAPSHOT
               TABLE 79 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
               TABLE 80 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
               TABLE 81 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (TON)
               TABLE 82 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (TON)
               TABLE 83 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
               TABLE 84 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
               TABLE 85 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (TON)
               TABLE 86 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (TON)
               TABLE 87 EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020–2023 (USD MILLION)
               TABLE 88 EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024–2029 (USD MILLION)
               TABLE 89 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2020–2023 (USD MILLION)
               TABLE 90 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
               TABLE 91 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
               TABLE 92 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
             12.3.1 EUROPE: RECESSION IMPACT ANALYSIS
                       FIGURE 50 INFLATION IN EUROPE: COUNTRY-LEVEL DATA, 2017-2022
                       FIGURE 51 EUROPE: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
             12.3.2 GERMANY
                       12.3.2.1 Rising focus on proactive healthcare to drive market
                                   TABLE 93 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
                                   TABLE 94 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
             12.3.3 FRANCE
                       12.3.3.1 Innovative products and investments in research and development to boost market growth
                                   TABLE 95 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
                                   TABLE 96 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
             12.3.4 UK
                       12.3.4.1 Rapidly aging population to propel market growth
                                   TABLE 97 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
                                   TABLE 98 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
             12.3.5 ITALY
                       12.3.5.1 Evolving dietary preferences to boost market growth
                                   TABLE 99 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
                                   TABLE 100 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
             12.3.6 SPAIN
                       12.3.6.1 Growing consumer interest in health supplements to propel drive demand
                                   TABLE 101 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
                                   TABLE 102 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
             12.3.7 REST OF EUROPE
                       TABLE 103 REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE,  2020–2023 (USD MILLION)
                       TABLE 104 REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE,  2024–2029 (USD MILLION)
     12.4 ASIA PACIFIC 
               FIGURE 52 ASIA PACIFIC VITAMIN K2 MARKET SNAPSHOT
               TABLE 105 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
               TABLE 106 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
               TABLE 107 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (TON)
               TABLE 108 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (TON)
               TABLE 109 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
               TABLE 110 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
               TABLE 111 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (TON)
               TABLE 112 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (TON)
               TABLE 113 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020–2023 (USD MILLION)
               TABLE 114 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024–2029 (USD MILLION)
               TABLE 115 ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2020–2023 (USD MILLION)
               TABLE 116 ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
               TABLE 117 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
               TABLE 118 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
             12.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
                       FIGURE 53 INFLATION IN ASIA PACIFIC: COUNTRY-LEVEL DATA, 2017-2022
                       FIGURE 54 ASIA PACIFIC: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
             12.4.2 CHINA
                       12.4.2.1 Surging use of digital media to disseminate healthcare information to propel market
                                   TABLE 119 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
                                   TABLE 120 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
             12.4.3 JAPAN
                       12.4.3.1 Consumer preferences for natural healthcare solutions to boost market growth
                                   TABLE 121 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
                                   TABLE 122 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
             12.4.4 INDIA
                       12.4.4.1 Strategic market penetration initiatives by various companies to drive market
                                   TABLE 123 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
                                   TABLE 124 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
             12.4.5 AUSTRALIA AND NEW ZEALAND
                       12.4.5.1 Changing consumer preferences and increasing health consciousness to drive demand
                                   TABLE 125 AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE,  2020–2023 (USD MILLION)
                                   TABLE 126 AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE,  2024–2029 (USD MILLION)
             12.4.6 REST OF ASIA PACIFIC
                       TABLE 127 REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE,  2020–2023 (USD MILLION)
                       TABLE 128 REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE,  2024–2029 (USD MILLION)
     12.5 ROW 
               TABLE 129 ROW: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
               TABLE 130 ROW: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
               TABLE 131 ROW: VITAMIN K2 MARKET, BY REGION, 2020–2023 (TON)
               TABLE 132 ROW: VITAMIN K2 MARKET, BY REGION, 2024–2029 (TON)
               TABLE 133 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
               TABLE 134 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
               TABLE 135 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (TON)
               TABLE 136 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (TON)
               TABLE 137 ROW: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020–2023 (USD MILLION)
               TABLE 138 ROW: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024–2029 (USD MILLION)
               TABLE 139 ROW: VITAMIN K2 MARKET, BY SOURCE, 2020–2023 (USD MILLION)
               TABLE 140 ROW: VITAMIN K2 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
               TABLE 141 ROW: VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
               TABLE 142 ROW: VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
             12.5.1 ROW: RECESSION IMPACT ANALYSIS
                       FIGURE 55 INFLATION IN ROW, COUNTRY-LEVEL DATA, 2017-2022
                       FIGURE 56 ROW: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
             12.5.2 SOUTH AMERICA
                       12.5.2.1 Collaboration among key market players to drive market growth
                                   TABLE 143 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE,  2020–2023 (USD MILLION)
                                   TABLE 144 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE,  2024–2029 (USD MILLION)
             12.5.3 MIDDLE EAST AND AFRICA
                       12.5.3.1 Developing regulatory landscape to propel market growth
                                   TABLE 145 MIDDLE EAST AND AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE,  2020–2023 (USD MILLION)
                                   TABLE 146 MIDDLE EAST AND AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE,  2024–2029 (USD MILLION)
 
13 COMPETITIVE LANDSCAPE (Page No. - 161)
     13.1 OVERVIEW 
     13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
               TABLE 147 OVERVIEW OF STRATEGIES ADOPTED BY KEY VITAMIN K2 VENDORS
     13.3 REVENUE ANALYSIS 
               FIGURE 57 REVENUE ANALYSIS FOR KEY COMPANIES IN LAST THREE YEARS,  2021–2023 (USD MILLION)
     13.4 MARKET SHARE ANALYSIS 
               FIGURE 58 SHARE OF LEADING COMPANIES IN VITAMIN K2 MARKET, 2023
               TABLE 148 VITAMIN K2 MARKET: DEGREE OF COMPETITION
     13.5 COMPANY VALUATION AND FINANCIAL METRICS 
             13.5.1 COMPANY VALUATION
                       FIGURE 59 COMPANY VALUATION OF KEY VITAMIN K2 VENDORS, 2023 (USD BILLION)
             13.5.2 EV/EBITDA
                       FIGURE 60 EV/EBITDA OF KEY COMPANIES, 2023
     13.6 BRAND/PRODUCT COMPARISON ANALYSIS 
               FIGURE 61 BRAND/PRODUCT COMPARISON ANALYSIS, BY PRODUCT TYPE
             13.6.1 MENAQUINGOLD
             13.6.2 MENAQ7
             13.6.3 K2VITAL
             13.6.4 VITAMK7
             13.6.5 MENATTO
     13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             13.7.1 STARS
             13.7.2 EMERGING LEADERS
             13.7.3 PERVASIVE PLAYERS
             13.7.4 PARTICIPANTS
                       FIGURE 62 VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
             13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                       13.7.5.1 Company footprint
                                   FIGURE 63 VITAMIN K2 MARKET: COMPANY FOOTPRINT
                       13.7.5.2 Regional footprint
                                   TABLE 149 VITAMIN K2 MARKET: REGIONAL FOOTPRINT
                       13.7.5.3 Product type footprint
                                   TABLE 150 VITAMIN K2 MARKET: PRODUCT TYPE FOOTPRINT
                       13.7.5.4 Application footprint
                                   TABLE 151 VITAMIN K2 MARKET: APPLICATION FOOTPRINT
                       13.7.5.5 Source footprint
                                   TABLE 152 VITAMIN K2 MARKET: SOURCE FOOTPRINT
     13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 
             13.8.1 PROGRESSIVE COMPANIES
             13.8.2 RESPONSIVE COMPANIES
             13.8.3 DYNAMIC COMPANIES
             13.8.4 STARTING BLOCKS
                       FIGURE 64 VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
             13.8.5 COMPETITIVE BENCHMARKING
                       13.8.5.1 Detailed list of key startups/SMEs
                                   TABLE 153 VITAMIN K2 MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2023
                       13.8.5.2 Competitive benchmarking of key startup/SMEs
                                   TABLE 154 VITAMIN K2 MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES
     13.9 COMPETITIVE SCENARIO AND TRENDS 
             13.9.1 PRODUCT LAUNCHES AND DEVELOPMENTS
                       TABLE 155 VITAMIN K2 MARKET: PRODUCT LAUNCHES AND DEVELOPMENTS, JANUARY 2020–JUNE 2024
             13.9.2 DEALS
                       TABLE 156 VITAMIN K2 MARKET: DEALS, JANUARY 2020–JUNE 2024
             13.9.3 EXPANSIONS
                       TABLE 157 VITAMIN K2 MARKET: EXPANSIONS, JANUARY 2020–JUNE 2024
             13.9.4 OTHERS
                       TABLE 158 VITAMIN K2 MARKET: OTHER DEVELOPMENTS, JANUARY 2020 - JUNE 2024
 
14 COMPANY PROFILES (Page No. - 182)
     14.1 KEY PLAYERS 
(Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Right to win, Strategic choices, and Weaknesses and Competitive threats)*
             14.1.1 GNOSIS BY LESAFFRE (NATTOPHARMA)
                       TABLE 159 GNOSIS BY LESAFFRE (NATTOPHARMA): COMPANY OVERVIEW
                       TABLE 160 GNOSIS BY LESAFFRE (NATTOPHARMA): PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 161 GNOSIS BY LESAFFRE (NATTOPHARMA): PRODUCT LAUNCHES AND DEVELOPMENTS
                       TABLE 162 GNOSIS BY LESAFFRE (NATTOPHARMA): DEALS
                       TABLE 163 GNOSIS BY LESAFFRE (NATTOPHARMA): OTHER DEALS/DEVELOPMENTS
             14.1.2 KAPPA BIOSCIENCE AS (BALCHEM CORP.)
                       TABLE 164 KAPPA BIOSCIENCE AS (BALCHEM CORP.): COMPANY OVERVIEW
                       FIGURE 65 KAPPA BIOSCIENCE AS (BALCHEM CORP.): COMPANY SNAPSHOT
                       TABLE 165 KAPPA BIOSCIENCE AS (BALCHEM CORP.): PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 166 KAPPA BIOSCIENCE AS (BALCHEM CORP.): PRODUCT LAUNCHES AND DEVELOPMENTS
                       TABLE 167 KAPPA BIOSCIENCE AS (BALCHEM CORP.): DEALS
                       TABLE 168 KAPPA BIOSCIENCE AS (BALCHEM CORP.): EXPANSIONS
                       TABLE 169 KAPPA BIOSCIENCE AS (BALCHEM CORP.): OTHER DEALS/DEVELOPMENTS
             14.1.3 J-OIL MILLS, INC.
                       TABLE 170 J-OIL MILLS, INC.: COMPANY OVERVIEW
                       FIGURE 66 J-OIL MILLS, INC.: COMPANY SNAPSHOT
                       TABLE 171 J-OIL MILLS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 172 J-OIL MILLS, INC.: PRODUCT LAUNCHES AND DEVELOPMENTS
                       TABLE 173 J-OIL MILLS, INC.: DEALS
             14.1.4 NOVOZYMES A/S
                       TABLE 174 NOVOZYMES A/S: COMPANY OVERVIEW
                       FIGURE 67 NOVOZYMES A/S: COMPANY SNAPSHOT
                       TABLE 175 NOVOZYMES A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 176 NOVOZYMES A/S: DEALS
             14.1.5 BASF SE
                       TABLE 177 BASF SE: COMPANY OVERVIEW
                       FIGURE 68 BASF SE: COMPANY SNAPSHOT
                       TABLE 178 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             14.1.6 SUNGEN BIOSCIENCE CO.,LTD
                       TABLE 179 SUNGEN BIOSCIENCE CO.,LTD: COMPANY OVERVIEW
                       TABLE 180 SUNGEN BIOSCIENCE CO.,LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             14.1.7 VESTA NUTRA
                       TABLE 181 VESTA NUTRA: COMPANY OVERVIEW
                       TABLE 182 VESTA NUTRA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             14.1.8 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.
                       TABLE 183 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
                       TABLE 184 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 185 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS
             14.1.9 MENADIONA
                       TABLE 186 MENADIONA: COMPANY OVERVIEW
                       TABLE 187 MENADIONA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 188 MENADIONA: PRODUCT LAUNCHES AND DEVELOPMENTS
             14.1.10 GENOFOCUS
                                   TABLE 189 GENOFOCUS: COMPANY OVERVIEW
                                   TABLE 190 GENOFOCUS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                                   TABLE 191 GENOFOCUS: PRODUCT LAUNCHES AND DEVELOPMENTS
             14.1.11 ANGELYEAST CO., LTD.
                                   TABLE 192 ANGELYEAST CO., LTD.: COMPANY OVERVIEW
                                   TABLE 193 ANGELYEAST CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             14.1.12 GENEFERM BIOTECHNOLOGY CO., LTD.
                                   TABLE 194 GENEFERM BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
                                   TABLE 195 GENEFERM BIOTECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             14.1.13 NAKODA CHEMICALS LTD.
                                   TABLE 196 NAKODA CHEMICALS LTD.: COMPANY OVERVIEW
                                   TABLE 197 NAKODA CHEMICALS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             14.1.14 HAIHANG INDUSTRY
                                   TABLE 198 HAIHANG INDUSTRY: COMPANY OVERVIEW
                                   TABLE 199 HAIHANG INDUSTRY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             14.1.15 CHEMICEA LIMITED
                                   TABLE 200 CHEMICEA LIMITED: COMPANY OVERVIEW
                                   TABLE 201 CHEMICEA LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             14.1.16 KYOWA HAKKO U.S.A., INC.
                                   TABLE 202 KYOWA HAKKO U.S.A., INC.: BUSINESS OVERVIEW
                                   TABLE 203 KYOWA HAKKO U.S.A., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
     14.2 STARTUPS/SMES 
             14.2.1 SEEBIO BIOTECH (SHANGHAI) CO.,LTD.
                       TABLE 204 SEEBIO BIOTECH (SHANGHAI) CO., LTD.: COMPANY OVERVIEW
             14.2.2 MAGNESIA GMBH
                       TABLE 205 MAGNESIA GMBH: COMPANY OVERVIEW
             14.2.3 FALCON TRADING INTERNATIONAL
                       TABLE 206 FALCON TRADING INTERNATIONAL: COMPANY OVERVIEW
             14.2.4 ABCO INDIA
                       TABLE 207 ABCO INDIA: COMPANY OVERVIEW
             14.2.5 ACT
                       TABLE 208 ACT: COMPANY OVERVIEW
*Details on Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Right to win, Strategic choices, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.
 
15 ADJACENT AND RELATED MARKETS (Page No. - 222)
     15.1 INTRODUCTION 
               TABLE 209 ADJACENT MARKETS TO VITAMIN K2 MARKET
     15.2 LIMITATIONS 
     15.3 DIETARY SUPPLEMENTS MARKET 
             15.3.1 MARKET DEFINITION
             15.3.2 MARKET OVERVIEW
                       TABLE 210 DIETARY SUPPLEMENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
                       TABLE 211 DIETARY SUPPLEMENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
     15.4 VITAMINS MARKET 
             15.4.1 MARKET DEFINITION
             15.4.2 MARKET OVERVIEW
                       TABLE 212 VITAMINS MARKET, BY REGION, 2017–2022 (USD MILLION)
                       TABLE 213 VITAMINS MARKET, BY REGION, 2023–2028 (USD MILLION)
 
16 APPENDIX (Page No. - 226)
     16.1 DISCUSSION GUIDE 
     16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 
     16.3 CUSTOMIZATION OPTIONS 
     16.4 RELATED REPORTS 
     16.5 AUTHOR DETAILS 

The study involved in estimating the current size of the vitamin k2 market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

This research study involved the extensive use of secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information useful for a technical, market-oriented, and commercial study of the vitamin k2 market.

In the secondary research process, various sources such as annual reports, press releases & investor presentations of companies, white papers, food journals, certified publications, articles from recognized authors, directories, and databases, were referred to identify and collect information.

Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key players, and market classification and segmentation as per the industry trends to the bottom-most level, regional markets, and key developments from both market- and technology-oriented perspectives.

Primary Research

Extensive primary research was conducted after obtaining information regarding the vitamin k2 market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, and the Rest of the World. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, research, and development teams, and related key executives from distributors, and key opinion leaders. Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to vitamin k2 product type, form, source, application, function, and region. Stakeholders from the demand side, such as pharmaceutical and food  & beverage manufacturers who use vitamin K2, were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage of vitamin k2 and the outlook of their business, which will affect the overall market.

Vitamin K2 Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

designation

Gnosis by Lesaffre (NattoPharma) (Norway)

Regional Sales Manager

Kappa Bioscience (Balchem Corp.) (US)

Marketing Manager

Sungen Bioscience Co., Ltd (China)

General Manager

Vesta Nutra (US)

Sales Manager

J-OIL MILLS, INC. (Japan)

Sales Manager

Novozymes A/S (Denmark)

Sales Executive

Market Size Estimation

Both the top-down and bottom-up approaches were used to estimate and validate the total market size. These approaches were also used to estimate the size of various dependent submarkets. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets were identified through extensive secondary research.
  • All shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the markets covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.
  • The research included the study of reports, reviews, and newsletters of top market players, along with extensive interviews for opinions from leaders, such as CEOs, directors, and marketing executives.

Global Vitamin K2 Market: Bottom-Up Approach.

Vitamin K2 Market Bottom Up Approach

To know about the assumptions considered for the study, Request for Free Sample Report

Global Vitamin K2 Market: Top-Down Approach.

Vitamin K2 Market Top Down Approach

Data Triangulation

After arriving at the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. To estimate the overall vitamin k2 market and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.

Market Definition

According to the National Institutes of Health (NIH) Office of Dietary Supplements (ODS), Vitamin K2, also called menaquinone (MK), is one of a group of fat-soluble vitamins that play a role in blood clotting and bone health. MK-4 and MK-7 are two specific subtypes of vitamin K2, also known as menaquinone. Both MK-4 and MK-7 are found naturally in some foods and can be taken as supplements. They both play a role in blood clotting and bone health by activating proteins like osteocalcin and matrix Gla protein (MGP).

Key Stakeholders

  • Raw material suppliers
  • Traders, distributors, and manufacturers & suppliers of vitamin k2
  • Food processors & food manufacturers
  • Government and research organizations
  • Trade associations and industry bodies
  • Regulatory bodies:
    • Food and Drug Administration (FDA)
    • European Commission
    • European Food Safety Authority (EFSA)
    • Food Standards Australia New Zealand (FSANZ)
    • European Communities
  • Associations, and commercial research & development (R&D) institutions:
  • Importers and exporters of vitamins
  • Global Alliance for Improved Nutrition (GAIN)
  • Food Fortification Initiative (FFI)
  • Food and Agriculture Organization (FAO)
  • United Nations International Children's Emergency Fund (UNICEF)
  • World Health Organization (WHO)
  • World Organization for Animal Health (WOAH)

Report Objectives

  • To define, segment, and forecast the global vitamin K2 market based on product types, forms, sources, function (qualitative), applications, and regions over a historical period from 2020 to 2023 and a forecast period from 2024 to 2029
  • To provide detailed information about the key factors influencing the market's growth (drivers, restraints, opportunities, and challenges).
  • To identify attractive opportunities in the market by determining the largest and fastest-growing segments across the regions.
  • To analyze the demand-side factors based on the following:
    • Impact of macro and microeconomic factors on the market
    • Shifts in demand patterns across different subsegments and regions
  • To strategically profile the key players and comprehensively analyze their core competencies.
  • To analyze competitive developments, such as partnerships, mergers & acquisitions, new product developments, and expansions & investments in the vitamin K2 market.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

The following customization options are available for the report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolio of each company.

Geographic Analysis

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

  • Further breakdown of the Rest of the European vitamin k2 market into key countries
  • Further breakdown of the Rest of Asia Pacific vitamin k2 market into key countries

Company Information

  • Detailed analyses and profiling of additional market players (up to five)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
FB 9049
Published ON
Jun, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Vitamin K2 Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback